Ramipril and risk of hyperkalemia in chronic hemodialysis patients;Rizik pojave hiperkalemije uz primjenu ramiprila u bolesnika na kroničnoj hemodijalizi

Collegium Antropologicum

Volumn 35, Issue 2, 2011, Pages 537-542

  Krajina Andričević, Mirna ^a   Zibar, Lada ^b   Juras, Karin ^c   Goll Barić, Sanda ^d   Barbić, Jerko ^b  

^a Vinkovci General Hospital   (Croatia)

^b JOSIP JURAJ STROSSMAYER UNIVERSITY OF OSIJEK   (Croatia)

^c University of Zagreb   (Croatia)

^d Hoffman LaRoche   (Croatia)

Author keywords

Angiotensin converting enzyme inhibitors; Hemodialysis; Hyperkalemia

Indexed keywords

ANTIHYPERTENSIVE AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; RAMIPRIL;

AGED; ARTICLE; CHEMICALLY INDUCED DISORDER; CLINICAL TRIAL; DRUG EFFECT; FEMALE; HUMAN; HYPERKALEMIA; MALE; MIDDLE AGED; RENAL REPLACEMENT THERAPY; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM;

AGED; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANTIHYPERTENSIVE AGENTS; FEMALE; HUMANS; HYPERKALEMIA; MALE; MIDDLE AGED; RAMIPRIL; RENAL DIALYSIS; RENIN-ANGIOTENSIN SYSTEM;

EID: 79959753215     PISSN: 03506134     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. MCCULLOUGH PA, J Am Coll Cardiol, 41 (2003) 725.
2. HERZOG CA, MA JZ, COLLINS AJ, N Eng J Med, 339 (1998) 799.
3. Al-Ahmad A, Rand WM, Manjunath G, Konstam MA, Salem DN, Levey AS, Sarnak MJ, Am Coll Card, 38 (2001) 955.
4. HAMPLE H, STERNBERG C, BERWECK S, Clin Nephrol, 58 (Suppl 1) (2002) 73.
5. ELLISON HD, OKUSA MD, SCHRIER RW, Mechanism of diuretic action. In: SSHRIER RW (Eds) Diseases of the kidney and urinary tract (Walters Kluwer Health, 2007).
6. ZIBAR L, BARBIĆ J, MILAS-AHIĆ J, JAKIĆ M, GALIĆ A, Hyperkalemia and blockade of renin-angiotensin system in chronically hemodialyzed patients (Fifteenth European Meeting on Hypertension, Milan, 2005).
7. YUSUF S, SLEIGHT P, POGUE J, BOSCH J, DAVIES R, DAGENAIS G, N Engl J Med, 342 (2000) 145.
8. HALL AS, WINTER C, BOGLE SM, MACKINTOSH AF, MURRAY GD, BALL SG, J Cardiovasc Pharmacol, 18 Suppl 2 (1991) 105.
9. Heart Outcomes Prevention Evaluation Study Investigators, Lancet, 355 (9200) (2000) 253.
10. Gruppo Italiano di Studi Epidemiologici in Nefrologia, Lancet, 349 (9069) (1997) 1857.
11. RUGGENENTI P, PERNA A, GHERARDI G, GASPARI F, BENINI R, REMUZZI G, Lancet, 353 (1998) 1252.
12. CHIU YL, CHIEN KL, LIN SL, CHEN YM, TSAI TJ, WU KD, Nephron Clin Pract, 109 (2008) 109.
13. HOU FF, ZHANG X, ZHANG GH, XIE D, CHEN PY, ZHANG WR, JIANG JP, LIANG M, WANG GB, LIU ZR, GENG RW, NEJM, 354 (2006) 131.
14. HAN SW, Won YW, Yi JH, Kim HJ, Nephrol Dial Transplant, 22(4) (2007) 1150.
15. KNOLL GA, SAHGAL A, NAIR RC, GRAHAM J, VAN WALRAVEN C, BURNS KD, Am JMed, 112(2) (2002) 110.
16. SCHREIBER BD, Am J Med Sci, 325 (2003) 179.
17. HUNT SA, ABRAHAM WT, CHIN MH, FELDMAN AM, FRANCIS GS, GANIATS TG, JESSUP M, KONSTAM MA, MANCINI DM, MICHL K, OATES JA, RAHKO PS, SILVER MA, STEVENSON LW, YANCY CW, J Am Coll Cardiol, 53 (15) (2009) e1.
18. ROY P, BOUCHARD J, AMYOT R, MADORE F, Am J Kidney Dis, 48(4) (2006) 645.
19. Albitar S, Genin R, Fen-Chong M, Serveaux MO, Bourgeon B, Nephrol Dial Transplant, 13 (1998) 1206.
20. Galić G, Tomić M, Galešić K, Kvesić A, Šoljić M, Lončar Z, Valenčić M, Martinović Ž, Vučkov Š, Coll Antropol 35 (2011) 93.
21. JAKIĆ M, LOVČIĆ V, KLARIĆ D, MIHALJEVIĆ D, ZIBAR L, JAKIĆ M, MARIĆ I, Coll Antropol, 34 Suppl 1 (2010) 181.